Dear Colleagues,

​

We take this opportunity to invite you to be a part of the 14th International Conference on the Chemistry and Biology of Mineralized Tissues to be held in The Netherlands on October 22-27 of 2023.  This prestigious event will be co-chaired by Drs. Bernard Ganss (Canada), Mina Mina (USA) and Nico Sommerdijk (The Netherlands).

 ​

We hope you will enjoy the exchange of scientific results and ideas, discussions with colleagues and friends, beautiful surroundings, and leisure activities at our conference location (Hotel De Bilderberg), nestled in the green surroundings of Oosterbeek.  This historic estate is located in the middle of the beautiful Veluwe forest, near the city of Arnhem.   VENUE INFORMATION       ​

​

From 177 registered participants at our 13th ICCBMT, we received more than 140 abstracts from 11 countries.  An oral program of more than 50 speakers was established through peer-review of the abstracts by our Scientific Advisory Board members.  The poster sessions contained almost 90 presentations, with close to a third of these also being presented as short "flash" talks (again, selected by SAB peer-review).  Also, fundraising enabled ICCBMT to allocate a substantial number of Young Investigator Awards ($1,000 each) to 35 trainee presenters to offset the cost to attend our 2019 conference.​

​

We look forward to your participation in the 14th International Conference on the Chemistry and Biology of Mineralized Tissues.

  14th ICCBMT Conference - The Netherlands                                        October 22-27, 2023

MELINDA J. DUER
Professor of Biological and Biomedical Chemistry
Department of Chemistry

University of Cambridge, UK

Title: TBA

​

Dr. Melinda Duer’s current research interests include nuclear magnetic resonance studies of biological materials, particularly human bone and vascular tissues. Pivotal discoveries were made by Duer on the involvement of poly(ADP-ribose) in bone mineralization (Science, 2014) and was among the first to connect the mechanisms of bone biomineralization with those in pathological calcifications (Cell Reports, 2019).

Duer’s research bridges fundamental and clinical research towards finding treatments for vascular calcification, a healthcare risk resulting from atherosclerosis, chronic kidney disease, diabetes, and aging. She also actively works towards valorizing scientific results as the co-founder and director of the start-up company Cambridge Oncology Ltd.

​

Conference Co-chairs​